Elevance Health (ELV) return on equity (ROE)

Return on equity · fiscal 2025
12.9%

Elevance Health (ELV) earned a return on equity of 12.9% in fiscal 2025 (the year ended December 31, 2025). That is 1.6 percentage points lower than the 14.5% of fiscal 2024. Figures as of 17 Nov 2026, 22:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
12.9%
Change on fiscal 2024
−1.6 pts
Highest on record
19.1%fiscal 2009
Lowest on record
9.8%fiscal 2016
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Elevance Health return on equity (ROE), in more detail

Across the 19 fiscal years on record (2007–2025), the highest was 19.1% in fiscal 2009 and the lowest 9.8% in fiscal 2016. The fiscal 2025 figure is higher than in 44% of the 18 earlier fiscal years on record, whose median is 13.5%.

History · 19 fiscal years

Return on equity by fiscal year

Elevance Health return on equity (ROE), year by year

Elevance Health (ELV) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202512.9% 1.6 pts down
202414.5% 0.8 pts down
202315.2% 1.0 pts down
202216.3% 0.8 pts down
202117.1% 3.3 pts up
202013.8% 1.4 pts down
201915.2% 2.0 pts up
201813.1% 1.4 pts down
201714.5% 4.7 pts up
20169.8% 1.3 pts down
201511.1% 0.5 pts up
201410.6% 0.5 pts up
201310.1% 1.1 pts down
201211.2% 0.2 pts down
201111.4% 0.8 pts down
201012.1% 7.0 pts down
200919.1% 7.5 pts up
200811.6% 2.9 pts down
200714.6%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Elevance Health and comparable companies
CompanyReturn on equityFiscal year
CVS Health CVS2.4%2025
HCA Healthcare HCA656.3%2020
GSK GSK34.9%2025
Regeneron Pharmaceuticals REGN14.4%2025
Elevance Health ELV12.9%2025
Cigna Group CI14.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ELV

Elevance Health, figure by figure

Elevance Health (ELV) overview: price, valuation and scorecardAll health care companies by market value

Elevance Health return on equity (ROE): questions and answers

What is Elevance Health's return on equity?

Elevance Health (ELV) earned a return on equity of 12.9% in fiscal 2025 (the year ended December 31, 2025). That is 1.6 percentage points lower than the 14.5% of fiscal 2024.

Is Elevance Health's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 44% of the 18 earlier fiscal years on record, whose median is 13.5%.

What are the highest and lowest return on equity figures on record for Elevance Health?

Across the 19 fiscal years on record (2007–2025), the highest was 19.1% in fiscal 2009 and the lowest 9.8% in fiscal 2016.

How is Elevance Health's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Elevance Health (ELV) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ELV/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.